Brian A Telfer
Overview
Explore the profile of Brian A Telfer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schoen Jr S, Prasov A, Candel I, Arshad S, Ottensmeyer M, Pierce T, et al.
IEEE Open J Eng Med Biol
. 2024 Nov;
5:877-884.
PMID: 39559779
Assessment of trauma-induced hemorrhage with ultrasound is particularly challenging outside of the clinic, where its detection is crucial. The current clinical standard for hematoma detection - the focused assessment with...
2.
Shabbir R, Telfer B, Dickie B, Reardon M, Babur M, Williams K, et al.
Cancer Genomics Proteomics
. 2024 Jun;
21(4):380-387.
PMID: 38944425
Background/aim: Patients with hypoxic bladder cancer benefit from hypoxia modification added to radiotherapy, but no biomarkers exist to identify patients with hypoxic tumours. We, herein, aimed to implement oxygen-enhanced MRI...
3.
Individualized Ultrasound-Guided Intervention Phantom Development, Fabrication, and Proof of Concept
Pierce T, Ottensmeyer M, Som A, Brattain L, Werblin J, Sutphin P, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2023 Dec;
2023:1-4.
PMID: 38082806
Commercial ultrasound vascular phantoms lack the anatomic diversity required for robust pre-clinical interventional device testing. We fabricated individualized phantoms to test an artificial intelligence enabled ultrasound-guided surgical robotic system (AI-GUIDE)...
4.
Wong C, Evangelou C, Sefton K, Leshem R, Zhang W, Gopalan V, et al.
Nat Commun
. 2023 Sep;
14(1):5983.
PMID: 37752135
Resistance mechanisms to immune checkpoint blockade therapy (ICBT) limit its response duration and magnitude. Paradoxically, Interferon γ (IFNγ), a key cytokine for cellular immunity, can promote ICBT resistance. Using syngeneic...
5.
Gupta J, Arshad S, Telfer B, Snider E, Convertino V
Biosensors (Basel)
. 2022 Dec;
12(12).
PMID: 36551134
Hemorrhage is the leading cause of preventable death from trauma. Accurate monitoring of hemorrhage and resuscitation can significantly reduce mortality and morbidity but remains a challenge due to the low...
6.
Zhang J, Pearson A, Sabherwal N, Telfer B, Ali N, Kan K, et al.
Cancer Res Commun
. 2022 Dec;
2(3):131-145.
PMID: 36466034
Targeting the human epidermal growth factor receptor 2 (HER2) became a landmark in the treatment of HER2-driven breast cancer. Nonetheless, the clinical efficacy of anti-HER2 therapies can be short-lived and...
7.
Pare J, Gjesteby L, Telfer B, Tonelli M, Leo M, Billatos E, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2022 Sep;
2022:1675-1681.
PMID: 36086232
Lung ultrasound (LUS) as a diagnostic tool is gaining support for its role in the diagnosis and management of COVID-19 and a number of other lung pathologies. B-lines are a...
8.
Gupta J, Telfer B, Convertino V
Annu Int Conf IEEE Eng Med Biol Soc
. 2022 Sep;
2022:1747-1752.
PMID: 36086009
Hemorrhage is the leading cause of preventable death from trauma. Traditionally, vital signs have been used to detect blood loss and possible hemorrhagic shock. However, vital signs are not sensitive...
9.
Wilcock D, Badrock A, Wong C, Owen R, Guerin M, Southam A, et al.
Cell Rep
. 2022 Jun;
39(12):110995.
PMID: 35732120
Dysregulated cellular metabolism is a cancer hallmark for which few druggable oncoprotein targets have been identified. Increased fatty acid (FA) acquisition allows cancer cells to meet their heightened membrane biogenesis,...
10.
Mason A, Hecht F, Davis S, Natale J, Hartogensis W, Damaso N, et al.
Sci Rep
. 2022 Mar;
12(1):4568.
PMID: 35296773
No abstract available.